Women and Infants Hospital of Rhode Island
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Women and Infants Hospital of Rhode Island sits in the top decile of US sponsors by registered trial count (#318 of 15,742 sponsors by registered trial count).
Women and Infants Hospital of Rhode Island: 65 sponsored US clinical trials, 14 recruiting.
Women and Infants Hospital of Rhode Island sponsors 65 registered US clinical trials on ClinicalTrials.gov, 14 of them currently recruiting, and 39 completed. 9 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postpartum Depression, with 3 trials.
Top-decile sponsor footprint
Women and Infants Hospital of Rhode Island ranks in the top decile of sponsors by registered trial count (#318 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
39 of 47 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
65 total, page 1 of 2
Bringing Medicines for HIV Prevention to a Family Planning Clinic
NCT06930508
Community-Partnered Doula Support for Neonatal Intensive Care Unit Families
NCT07437131
Combined Oral Motor Stimulation and Language on Preterm Infant Feeding
NCT05861531
Rhode Island Community-based Maternal Support Services
NCT07446374
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
NCT06969326
Intravesical Gentamicin to Prevent Recurrent UTI
NCT06332781
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
NCT06842875
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
NCT06849869
Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
NCT06135636
Early Diagnosis and Intervention for Fetal Malposition in Active Labor and Its Impact on Mode of Delivery
NCT05881629
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
NCT05806164
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
NCT05462704
The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
NCT05625373
RCT of Pain Perception With Fast and Slow Tenaculum Application
NCT05458037
GEM: Impact of a Video Education Tool on Decisional Conflict Among Prenatal Patients
NCT06771453
Feasibility & Acceptability of App-based Cognitive Behavioral Therapy for Postpartum Depression Prevention
NCT06365645
Prenatal Genetics Chatbot Trial: Prenatal GENEie
NCT07077707
Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection
NCT06953271
Ear Acupuncture for Pain and Anxiety Management in Early Labor
NCT06678893
Pilot Randomized Control Trial to Assess the Impact of Video Education on Postpartum Care Knowledge and Attendance Among Pregnant Individuals With Diabetes
NCT07009106
Baby2Home (B2H) Mobile Health Application
NCT05595486
App-based Remote Blood Pressure Monitoring
NCT05595629
Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
NCT05098067
Race, Ethnicity, Socioeconomic Status and Prolapse-rElated Decisional ConflicT
NCT04977141
Postpartum Visit Timing and the Effect on Visit Attendance
NCT05399784
A Pilot Study Assessing the Feasibility and Effectiveness of a Breastfeeding Educational Video on Breastfeeding Rates
NCT04692480
Effect of Video Education on Patients' Knowledge and Attitudes of Privacy in Prenatal Genetics
NCT04420858
Strength for U in Relationship Empowerment
NCT04218864
Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus
NCT03651531
VAlidation of a Lower Cost aneUploidy scrEen
NCT03087357
CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure
NCT03670732
Intervention for Battered Sheltered Women With Substance Use Randomized Trial
NCT02629133
Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus
NCT02596932
The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies
NCT02698527
Intervention for IPV Perinatal Women- RCT
NCT02370394
Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis
NCT02143154
Prenatal Screening for Down Syndrome With DNAFirst
NCT01966991
The Early ABCs Study
NCT02055573
Neurophysiological Maturation Correlate With Clinical Milestones
NCT03722901
Prophylactic Antibiotics Prior TO Cesarean Section IN Obese Women
NCT01810354
Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus
NCT01819519
HMB- Data Collection Methods
NCT02001324
NICU Parent Education Program
NCT02528227
Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers
NCT01482832
Sober Network IPT for Perinatal Women With Comorbid Substance Use and Depression
NCT01550913
A Trial of 2% Lidocaine Gel for Intrauterine Device (IUD) Insertion
NCT01292447
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
NCT01296035
Computerized-Adaptive Testing: Feasibility In Women With Pelvic Floor Disorders (CAT)
NCT01288703
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
NCT00986206
Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents
NCT00831883
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 3 | 5 |
| Phase 4 | 4 |
What is open in the Women and Infants Hospital of Rhode Island pipeline
14 recruiting of 65 indexed (22% open); 39 completed (60%).
Phase mix: 9 late (III/IV) vs 8 early (I/II) (balanced across stages).
Top condition: Postpartum Depression (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Women and Infants Hospital of Rhode Island: open-pipeline peers nationwide
Peers matched on 65 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
Women and Infants Hospital of Rhode Island sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 65 trials (± recruiting share)
- BeiGene · 65 trials · 14% recruiting
- Glaxo Wellcome · 65 trials · 0% recruiting
- LEO Pharma · 65 trials · 5% recruiting
- Neurocrine Biosciences · 65 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Merck Sharp & Dohme · 22% recruiting · 558 trials
- UNC Lineberger Comprehensive Cancer Center · 22% recruiting · 366 trials
- AbbVie · 21% recruiting · 526 trials
- Florida State University · 21% recruiting · 219 trials
Related
What to do with this Women and Infants Hospital of Rhode Island page
65 registered trials is a research-attention snapshot, not an endorsement of Women and Infants Hospital of Rhode Island or any single study.
- 14 of Women and Infants Hospital of Rhode Island's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Postpartum Depression is the condition Women and Infants Hospital of Rhode Island studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postpartum Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Women and Infants Hospital of Rhode Island pipeline card: 65 registered trials from official public datasets.Report a data error.